Icatolimab (Anti-BTLA / CD272)

Icatolimab (Anti-BTLA / CD272) is a recombinant human monoclonal antibody which targets human BTLA protein. It neutralizes the interaction between BTLA and HVEM(Herpesvirus entry mediator). MW :145.5 KD.
Supplier Selleck Chemicals
Product # A2581
Sku # A2581-1mg
Pricing 1mg, $539.00
Feedback